SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Aug 15 3:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: far east who wrote (897)11/26/1997 9:14:00 AM
From: NeuroInvestment  Read Replies (1) of 1359
 
I am a bit puzzled as to why there is all this breathless anticipation of the earnings report. Since revenues from AHP are booked one quarter late (to ensure that it reflects monies actually received from AHP, not just projected), revenue figures will reflect sales of Redux up to June 30, before the Redux story imploded. Those are completely irrelevant now; Interneuron's brief tenure as an earnings-driven company is temporarily suspended, Redux sales up to 6/30 are moot.IPIC is now an events-driven company until CerAxon reaches the market (this sets aside PMS Escape revenues, which showed regional promise last fiscal year, but it will be the results of the national launch that will be far more important, and not discernible until perhaps 2Q:98). Other than updating us as to cash reserves (which off the top of my head should be slightly over $120 million), the report is likely to be somewhat anachronistic. NeuroInvestment
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext